Cohort of Patients With Chronic Myelomonocytic Leukemia | NCT07512882 | Trialant

Cohort of Patients With Chronic Myelomonocytic Leukemia | NCT07512882 | Trialant

Arms/Interventions Module

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Sampling	Biological	Blood samples taken as part of a scheduled assessment within the context of medical care Standard sample: 2 x 10 mL EDTA tubes For the initial assessment: 1 x 10 mL dry tube At the request of the research teams: one EDTA tube may be replaced by a heparinised or citrated tube, depending on the planned research. Bone marrow samples, taken during a scheduled myelogram as part of medical care Myelogram: 1 x 2 mL EDTA tube In exceptional cases, during a scheduled surgical procedure, a tissue sample will be considered in consultation with the surgeon (affected tissue, surrounding healthy tissue).

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Understanding the pathophysiology of chronic myelomonocytic leukaemia	optimise diagnosis, improve prognostic stratification, identify new treatment options and assess patients' response to proposed treatments through the analysis of blood or bone marrow samples collected as part of routine care or clinical trials	through study completion, an average of 15 years

Contacts/Locations Module

Ancestor Terms

ID	Term
D009370	Neoplasms by Histologic Type
D009369	Neoplasms
D006402	Hematologic Diseases
D006425	Hemic and Lymphatic Diseases
D007951	Leukemia, Myeloid
D054437	Myelodysplastic-Myeloproliferative Diseases
D001855	Bone Marrow Diseases
D002908	Chronic Disease
D020969	Disease Attributes
D010335	Pathologic Processes
D013568	Pathological Conditions, Signs and Symptoms